Financial Expert Sumeet Bagadia Identifies Five Stocks for Immediate Investment Consideration

Indian Stock Market Report - March 6, 2024

Market Overview

The Indian stock market extended its losing streak on Friday, with the benchmark indices declining due to the ongoing conflict in the Middle East. The Nifty 50 and Sensex fell 1.20% and 1.39%, respectively, while the broader market showed weakness but managed to outperform the benchmarks.

Nifty Outlook

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

The Nifty 50 closed near 24,450, reflecting continued weakness in the broader market sentiment. The index formed a long bearish candle on the daily chart, indicating persistent supply at higher levels. Immediate support is seen around 24,300-24,350, which could act as a short-term stabilization zone. Resistance is placed near 24,600-24,650, and only a decisive recovery above this band could trigger short-covering and improve near-term momentum.

Bank Nifty Outlook

The Bank Nifty also remained under heavy selling pressure, closing near 57,780. The index formed a strong bearish candle and slipped below the psychological levels 58,000 mark, indicating continuation of the corrective phase in the banking space. Immediate support is placed around 57,400-57,500, which is crucial to prevent further downside momentum. Resistance is seen near 58,000-58,100, and only a sustained move above this band may trigger a technical bounce and stabilize short-term sentiment.

Stock Recommendations

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Sumeet Bagadia, Executive Director at Choice Broking, recommends the following five shares to buy:

1. Aditya Birla Sun Life Amc: Buy at ₹924, Target ₹980, Stop Loss ₹880
2. Aster DM Healthcare: Buy at ₹672, Target ₹714, Stop Loss ₹648
3. CG Power and Industrial Solutions: Buy at ₹715, Target ₹768, Stop Loss ₹693
4. Astral: Buy at ₹1689, Target ₹1800, Stop Loss ₹1620
5. Krishna Institute Of Medical Sciences: Buy at ₹720, Target ₹772, Stop Loss ₹690